The Science and Medicine of
Acute Coronary Syndrome

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Release Date:

May 1, 2008

Expiration Date:

May 1, 2010

Intended Audience:

This symposium has been conceived for the following audience:

• Cardiologists, non-invasive specialists
• Prevention-oriented cardiologists
• Cardiologists, invasive specialists
• Cardiovascu lar nurses
• Coronary care unit (CCU) specialists and directors
• Specialists in invasive vascular management
• Program direc tors, cardiovascular medicine
• Fellows in cardiovascular medi cine
• Clinical pharmacists and pharmacologists
• Pharmacy directors (cardiovascular medicine)
• Investigators and clinical trial specialists, invasive cardiology

Registration:

Enrollment for this WebCAST is complimentary, and clinicians are invited to participate in this CME-certified WebCAST and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Supported by an independent educational grant from The Medicines Company.
 

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Massachusetts Medical School, Office of CME and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Faculty Disclosures:

Sunil V. Rao, MD, FACC
Grant/Research Support: Cordis
Consultant: Sanofi-Aventis, The Medicines Company
Speaker’s Bureau: Sanofi-Aventis, The Medicines Company, Cordis

Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FAHA
Grant/Research Support: The Medicines Co., BMS, Sanofi-Aventis, Eisai, Ethicon
Consultant: Astra Zeneca, BMS, Cardax, Centocor, Daiichi-Sankyo, Eisai, Eli Lilly, GSK, Millennium, Otsuka, Paringenix, PDL, Sanofi-Aventis, Schering Plough, The Medicines Co., tns Healthcare
Speaker’s Bureau: BMS, Sanofi-Aventis, The Medicines Co

Harold L. Dauerman, MD
Consultant: The Medicines Company, Abbott Vascular
Research Grants: Abbott Vascular and Boston Scientific
Fellowship Support: Boston Scientific, Cordis/JNJ and Medtronic

Gregg W. Stone, MD
Grant/Research Support: The Medicines Co. and Boston Scientific

Ron Waksman, MD, FACC
Consultant and speaker or research grant support: Medtronic, Boston Scientific, Biotronik, GSK, Sanofi, BMS

Program Faculty:

Sunil V. Rao, MD, FACC
Host, Duke University Medical Center Cardiac Catheterization Conference
Assistant Professor of Medicine
Duke Uni versity Medical Center
Director, Cardiac Catheterization Laboratories
Durham VA Medical Center
Durham, North Carolina

DISTINGUISHED FACULTY PRESENTERS

Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FAHA
Associ ate Director, Cardiovascular Coordinating Center
Staff, Cardiac, Peripheral, and Ca rotid Intervention
Associate Professor of Medicine
Department of Cardiovascular Medicine
Cleveland Clinic

Harold L. Dauerman, MD
Di rector, Cardiovascular Catheterization Laboratories
Professor of Medicine
University of Vermont/Fletcher Allen Health Care
Burlington, Vermont

Gregg W. Stone, MD
Professor of Medicine
Director of Cardiovascu lar Research and Education
Center for Interventional Vascular Therapy
Columbia University Medical Center
Chairman, The Cardiovascular Research Foundation
New York City, New York

Ron Waksman, MD, FACC
As sociate Director, Division of Cardiology
Washington Hospital Center
Director of Experimental Angioplasty and Vascular Brachytherapy
Cardiovascular Research Institute
Washington Hospital Center
Clinical Professor of Medicine
George town University
Washington, DC

Educational Objectives:

Participants in this CME-certified WebCAST will:

• Learn to identify signs, symptoms, and prognostic features of acute coronary syndrome and related ischemic conditions, and their implications for invasive vascular management.
  
• Learn how recently issued AHA/ACC Guidelines for Non ST-Elevation Myocardial Infarction are best applied to appropriately risk-stratified patients with UA and NSTEMI.
  
• Learn to assess and implement optimal pharmacologic interventions, especially antithrombotic therapy in the upstream setting, for patients presenting with manifestations of UA, NSTEMI, STEMI, and related conditions.
  
• Learn to understand the implications of recent clinical data, trials, and recommendations on switching antithrombotic therapy in patients who present with acute ischemic coronary syn­dromes, with an emphasis on determining when switching from one agent to another is appropri ate, safe, and feasible, and when switching among antithrombotic agents may be problematic.
  
• Learn to characterize, identify, and evaluate the safety, efficacy, and side effects of myr iad therapeutic options used for acute ischemic coronary syndromes including, aspirin, antiplatelet agents, direct thrombin inhibitors, UFH, LMWHs, and factor Xa inhibitors.
  
• Learn to understand the specific advantages and potential disadvantages of phar macologic agents currently used to reduce ischemic and bleeding end points in the setting of cardiovascular emergencies.
  

Disclaimer:

Copyright © 2011 Resources, LLC All rights reserved.

Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.

Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.

Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © 2011 Resources, LLC All rights reserved.